Form 4: Guardant Health CFO Michael Bell Reports Stock Transactions
SEC Form 4 Filing
Michael Bell, CFO of Guardant Health, reports the vesting of restricted stock units and associated tax withholding.
Summary
- On March 15, 2024, Michael Bell, the Chief Financial Officer of Guardant Health, Inc., engaged in transactions involving the company's common stock.
- Bell acquired 1,233 shares of common stock through the vesting of restricted stock units (RSUs) at a price of $0.
- Simultaneously, 429 shares were disposed of to cover tax withholding obligations at a price of $17.74 per share.
- Following these transactions, Bell directly owns 12,453 shares of Guardant Health common stock and 9,864 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine filing reflecting standard compensation practices; it doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they primarily reflect internal compensation adjustments.
Key Dates
| Date | Description |
|---|---|
| 03/15/2023 | 25% of the shares subject to the restricted stock unit award granted on May 9, 2022 vested. |
| 03/15/2024 | Date of the reported transactions: vesting of RSUs and tax withholding. |
| 03/18/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.